The pharmaceutical industry makes an important contribution to Europe's and the world's well-being. It is a strategic sector due to its economic as well as its public health dimension. Europe needs to preserve a vibrant pharmaceutical sector as an essential precondition to ensure a high level of public health protection and a competitive knowledge-based economy.

Latest news

• 24/04/2012

  Mission Growth: Europe at the Lead of the New Industrial Revolution

• 23/04/2012

  New lists of standards for electromagnetic compatibility, pressure equipment/vessels, and radio/telecom terminal equipment

• 29/03/2012

  SME Envoys call upon action to eliminate access barriers for SMEs to public procurement

Upcoming events

• 29/05/2012 > 29/05/2012

  Brussels

  Register now! Conference "Mission Growth: Europe at the Lead of the New Industrial Revolution"

Latest publications

• 07/05/2012

  Innovation in healthcare and access to medicines

• 30/03/2012

  Your gateway to EU funding

• 08/03/2012

  EU's strengths and weaknesses in terms of innovation

Latest contracts and grants

• Deadline: 25/06/2012

  Sustainable Industry Low Carbon scheme (SILC) I - Short-term innovation measures - Action 38/G/ENT/CIP/12/D/N02S00

• Deadline: 27/07/2012

  47/G/ENT/CIP/12/E/N02S005 - European corporate social responsibility award scheme

• Deadline: 14/09/2012

  41/G/ENT/CIP/12/E/N02S001 - European Multistakeholder platforms on corporate social responsibility in relevant business sectors

Latest public consultations

• Deadline: 12/06/2012

  Chemicals: ECHA draft working proramme 2013 - 15

Key content

• Pricing and reimbursement of Medicinal products: Transparency Directive

• Public Consultation Transparency Directive

• Competitiveness in Healthcare industries

• Legislation, reports and studies